Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000
Avacta Group PLC (AVCT.L) FDA Approval of IND Application for AVA6000
Omega Diagnostics is confident that it can stem losses as the sales momentum increases
Omega Diagnostics, a medical testing company, has reported greater interim losses despite an increase in revenues.
Omega Diagnostics Gp (ODX.L) Half-year Report
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021
Abingdon Health PLC (ABDX.L) Preliminary Results
York, U.K. 18 November 2021: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces its preliminary results for the year
Omega Diagnostics Gp (ODX.L) Notice of Results and Investor Presentation
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, announces it will release its interim results for the
Omega Diagnostics Gp (ODX.L) Update on CTDA Regulations
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, notes the UK Health Security Agency’s Medical Devices (Coronavirus
Avacta Group PLC (AVCT.L) Update on UK Availability of AffiDX Test
Update on UK Availability of AffiDX SARS-CoV-2 Lateral Flow Rapid Antigen Test following Implementation of CTDA Regulations
Omega Diagnostics Gp (ODX.L) Partnership with DAM Health and initial LFT order
Agreement for Omega’s Market Leading, UK Manufactured VISITECT ® COVID-19 Antigen LFT
Omega Diagnostics Gp (ODX.L) AGM Statement
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, will hold its Annual General Meeting (‘AGM’) today at 11am at Omega
Abingdon Health PLC (ABDX.L) Launch of Semi-Quantitative Accessory to AbC-19T
To help indicate the strength of antibody response and possible immunity
Avacta Group PLC (AVCT.L) New appointments to Scientific Advisory Board
Avacta announces new appointments to the Scientific Advisory Board of its Therapeutics Division
